Our study first detected m6A levels in colorectal cancer tissues and further demonstrated that ZCCHC4 was a key factor in altering m6A levels, which made it possible to observe ZCCHC4, a newly identified methyltransferase from the perspective of m6A for the first time. The gene discussed is ZCCHC4; the disease is colorectal cancer.